DE60012554D1 - Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit - Google Patents

Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Info

Publication number: DE60012554D1
Authority: DE; Germany
Prior art keywords: barreness; endometriosis; bzw; treatment; beta agonists
Prior art date: 1999-10-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60012554T

Other languages

English (en)

Other versions

DE60012554T2 (de

Inventor

William J Bologna

Dominique De Ziegler

Howard L Levine

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Columbia Laboratories Bermuda Ltd

Original Assignee

Columbia Laboratories Bermuda Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-05

Filing date

2000-10-04

Publication date

2004-09-02

2000-10-04 Application filed by Columbia Laboratories Bermuda Ltd filed Critical Columbia Laboratories Bermuda Ltd

2004-09-02 Application granted granted Critical

2004-09-02 Publication of DE60012554D1 publication Critical patent/DE60012554D1/de

2005-11-24 Publication of DE60012554T2 publication Critical patent/DE60012554T2/de

2020-10-05 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Inorganic Chemistry (AREA)
Pregnancy & Childbirth (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

DE60012554T 1999-10-05 2000-10-04 Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit Expired - Lifetime DE60012554T2 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US15775499P	1999-10-05	1999-10-05
US157754P		1999-10-05
US66838400A	2000-09-25	2000-09-25
US668384		2000-09-25
PCT/EP2000/009708 WO2001024788A2 (en)	1999-10-05	2000-10-04	Treating endometriosis or infertility, or improving fertility

Publications (2)

Publication Number	Publication Date
DE60012554D1 true DE60012554D1 (de)	2004-09-02
DE60012554T2 DE60012554T2 (de)	2005-11-24

Family

ID=26854456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60012554T Expired - Lifetime DE60012554T2 (de)	1999-10-05	2000-10-04	Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Country Status (28)

Country	Link
EP (1)	EP1220667B1 (de)
JP (2)	JP2003510354A (de)
KR (1)	KR100738724B1 (de)
CN (1)	CN1218694C (de)
AR (1)	AR028487A1 (de)
AT (1)	ATE271860T1 (de)
AU (1)	AU780736B2 (de)
BR (1)	BR0014548A (de)
CA (1)	CA2385974C (de)
CO (1)	CO5251423A1 (de)
DE (1)	DE60012554T2 (de)
DK (1)	DK1220667T3 (de)
ES (1)	ES2223581T3 (de)
GE (1)	GEP20043313B (de)
HK (1)	HK1044120B (de)
HU (1)	HU225990B1 (de)
IL (2)	IL148784A0 (de)
MA (1)	MA25501A1 (de)
MX (1)	MXPA02003453A (de)
MY (1)	MY129518A (de)
NO (1)	NO329663B1 (de)
NZ (1)	NZ518429A (de)
PE (1)	PE20010742A1 (de)
PT (1)	PT1220667E (de)
TR (1)	TR200200899T2 (de)
TW (1)	TWI280877B (de)
UA (1)	UA74168C2 (de)
WO (1)	WO2001024788A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101327326A (zh) *	2001-10-29	2008-12-24	哥伦比亚实验室(百慕大群岛)有限公司	阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en)	2001-10-29	2013-04-23	Columbia Laboratories, Inc.	Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es)	2003-07-16	2006-11-01	Italfarmaco, S.A.	Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (de)	2006-06-29	2008-01-02	Polichem S.A.	Verwendung einer hydrophilen Matrix, die ein Polyacrylsäurederivat, einen Celluloseether und ein Zerfallsmittel enthält, für die Herstellung eines Medikamentes zur Behandlung weiblicher Genitalstörungen
ES2344673B1 (es)	2008-08-07	2011-05-03	Italfarmaco, S.A.	Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es)	2008-12-19	2011-04-28	Italfarmaco, S.A.	Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
US20130018027A1 (en) *	2010-03-22	2013-01-17	Repros Therapeutics Inc.	Compositions and methods for non-toxic delivery of antiprogestins
KR101010031B1 (ko) *	2010-12-08	2011-01-21	류상범	흡수식 냉온수기용 엘리미네이터
SG11201407397WA (en)	2012-05-31	2014-12-30	Repros Therapeutics Inc	Formulations and methods for vaginal delivery of antiprogestins
JP6343619B2 (ja)	2012-11-02	2018-06-13	レプロスセラピューティクスインコーポレイティド	プロゲステロン依存性病態を処置する方法およびその組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4241087A (en) *	1979-04-02	1980-12-23	William H. Rorer, Inc.	Dysmenorrhea treatment
AU5068090A (en) *	1989-03-07	1990-09-13	Adeza Biomedical Corporation	Endometriosis diagnosis methods and reagents
JP2602456B2 (ja) *	1990-04-12	1997-04-23	雪印乳業株式会社	子宮内膜症治療剤
IT1251114B (it) *	1991-07-26	1995-05-04	Farcon Ag	Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) *	1997-09-12	2004-09-30	Columbia Laboratories (Bermuda) Ltd.	Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

2000
- 2000-04-10 UA UA2002043631A patent/UA74168C2/uk unknown
- 2000-10-03 MY MYPI20004608A patent/MY129518A/en unknown
- 2000-10-03 PE PE2000001044A patent/PE20010742A1/es not_active Application Discontinuation
- 2000-10-04 WO PCT/EP2000/009708 patent/WO2001024788A2/en not_active Ceased
- 2000-10-04 BR BR0014548-3A patent/BR0014548A/pt not_active Application Discontinuation
- 2000-10-04 ES ES00964272T patent/ES2223581T3/es not_active Expired - Lifetime
- 2000-10-04 EP EP00964272A patent/EP1220667B1/de not_active Expired - Lifetime
- 2000-10-04 PT PT00964272T patent/PT1220667E/pt unknown
- 2000-10-04 HU HU0203050A patent/HU225990B1/hu unknown
- 2000-10-04 AU AU75250/00A patent/AU780736B2/en not_active Ceased
- 2000-10-04 TR TR2002/00899T patent/TR200200899T2/xx unknown
- 2000-10-04 CO CO00075387A patent/CO5251423A1/es not_active Application Discontinuation
- 2000-10-04 HK HK02105660.6A patent/HK1044120B/en not_active IP Right Cessation
- 2000-10-04 CA CA2385974A patent/CA2385974C/en not_active Expired - Fee Related
- 2000-10-04 MX MXPA02003453A patent/MXPA02003453A/es active IP Right Grant
- 2000-10-04 AT AT00964272T patent/ATE271860T1/de active
- 2000-10-04 JP JP2001527787A patent/JP2003510354A/ja active Pending
- 2000-10-04 GE GE4769A patent/GEP20043313B/en unknown
- 2000-10-04 DK DK00964272T patent/DK1220667T3/da active
- 2000-10-04 NZ NZ518429A patent/NZ518429A/en not_active IP Right Cessation
- 2000-10-04 KR KR1020027004330A patent/KR100738724B1/ko not_active Expired - Fee Related
- 2000-10-04 AR ARP000105228A patent/AR028487A1/es unknown
- 2000-10-04 CN CNB008138079A patent/CN1218694C/zh not_active Expired - Fee Related
- 2000-10-04 IL IL14878400A patent/IL148784A0/xx active IP Right Grant
- 2000-10-04 DE DE60012554T patent/DE60012554T2/de not_active Expired - Lifetime
- 2000-10-27 TW TW089120706A patent/TWI280877B/zh not_active IP Right Cessation
2002
- 2002-03-20 IL IL148784A patent/IL148784A/en not_active IP Right Cessation
- 2002-04-04 NO NO20021591A patent/NO329663B1/no not_active IP Right Cessation
- 2002-04-04 MA MA26584A patent/MA25501A1/fr unknown
2009
- 2009-10-29 JP JP2009249023A patent/JP2010018639A/ja active Pending

Also Published As

Publication number	Publication date
KR100738724B1 (ko)	2007-07-12
HK1044120B (en)	2004-12-17
PE20010742A1 (es)	2001-07-19
MA25501A1 (fr)	2002-07-01
NZ518429A (en)	2004-02-27
HUP0203050A3 (en)	2006-02-28
EP1220667B1 (de)	2004-07-28
BR0014548A (pt)	2002-06-04
NO20021591D0 (no)	2002-04-04
CA2385974C (en)	2010-01-26
CO5251423A1 (es)	2003-02-28
NO329663B1 (no)	2010-11-29
ATE271860T1 (de)	2004-08-15
DE60012554T2 (de)	2005-11-24
KR20020062285A (ko)	2002-07-25
WO2001024788A3 (en)	2001-12-06
EP1220667A2 (de)	2002-07-10
HUP0203050A2 (hu)	2003-02-28
CN1377264A (zh)	2002-10-30
JP2003510354A (ja)	2003-03-18
IL148784A (en)	2006-12-31
CA2385974A1 (en)	2001-04-12
AU7525000A (en)	2001-05-10
JP2010018639A (ja)	2010-01-28
MXPA02003453A (es)	2002-08-20
MY129518A (en)	2007-04-30
GEP20043313B (en)	2004-03-10
TWI280877B (en)	2007-05-11
TR200200899T2 (tr)	2002-07-22
ES2223581T3 (es)	2005-03-01
HK1044120A1 (en)	2002-10-11
PT1220667E (pt)	2004-11-30
AU780736B2 (en)	2005-04-14
AR028487A1 (es)	2003-05-14
WO2001024788A2 (en)	2001-04-12
NO20021591L (no)	2002-05-28
IL148784A0 (en)	2002-09-12
UA74168C2 (uk)	2005-11-15
DK1220667T3 (da)	2004-12-06
CN1218694C (zh)	2005-09-14
HU225990B1 (en)	2008-02-28

Publication	Publication Date	Title
ATE250575T1 (de)	2003-10-15	Ep4 rezeptor selektive agonisten zur behandlung der osteoporose
DE60019556D1 (de)	2005-05-25	2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de)	2005-05-25	2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60028358D1 (de)	2006-07-06	Hmg1 antagonisten zur behandlung von entzündungen
DE60023043T2 (de)	2006-06-14	(S,S)-Reboxetin zur Behandlung von Inkontinenz
ATE275145T1 (de)	2004-09-15	Chinazolinderivate zur behandlung von tumoren
DE60013009D1 (de)	2004-09-23	Vorrichtung zur Kupfer-Elektroplattierung mit der Möglichkeit einer thermischen Behandlung
DE69931975D1 (de)	2006-07-27	FSH Mimetika zur Behandlung von Infertilität
DE69912972D1 (de)	2003-12-24	Antibiotische zusammensetzungen zur behandlung des auges
ATE417602T1 (de)	2009-01-15	Mittel zur behandlung von erkrankungen der speiseröhre
DE69934877D1 (de)	2007-03-08	Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE60032905D1 (de)	2007-02-22	Selektive iglur5 rezeptorantagonisten zur behandlung der migräne
DE69819515D1 (de)	2003-12-11	Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
DE60031790D1 (de)	2006-12-21	Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen
DE60012554D1 (de)	2004-09-02	Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit
DE69836464D1 (de)	2007-01-04	Orale Zusammensetzung für die Behandlung von übelriechendem Atem
MXPA03004303A (es)	2003-08-19	DERIVADOS SUSTITUIDOS DE ACIDO AMINO-FURAN-2-IL-ACETICO Y ACIDO AMINO-TIEN-2-IL-ACETICO Y SU USO PARA EL TRATAMIENTO DE MIGRAnA Y DOLOR.
DE59707096D1 (de)	2002-05-29	Haarbehandlungsmittel zur Festigung der Haare
DE69905214D1 (de)	2003-03-13	Mittel zur Behandlung der Osteoporose
ATE261434T1 (de)	2004-03-15	Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69931487D1 (de)	2006-06-29	Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE60021252D1 (de)	2005-08-18	Antikonvulsiva zur behandlung von autismus
DE60006412D1 (de)	2003-12-11	Oxazinochinolone zur behandlung von viralen infektionen
ATE250580T1 (de)	2003-10-15	Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie
DE50009813D1 (de)	2005-04-21	Kombinationpräparat zur behandlung von sexueller dysfunktion

Legal Events

Date	Code	Title	Description
2005-06-09	8332	No legal effect for de
2005-06-23	8370	Indication related to discontinuation of the patent is to be deleted
2005-08-25	8364	No opposition during term of opposition
2012-02-01	R082	Change of representative	Ref document number: 1220667 Country of ref document: EP Representative=s name: TERGAU & WALKENHORST PATENT- UND RECHTSANWAELTE, 9